MARSHALL U COBRE: ADMINISTRATIVE COREOIR=
马歇尔·U·科布雷:行政核心=
基本信息
- 批准号:7382179
- 负责人:
- 金额:$ 44.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. As required by COBRE guidelines, an administrative core will be established and directed by the PI, Dr. Niles. This core will be responsible for all financial aspects of the COBRE. This will include tracking individual project/core budgets, placing orders, approving invoices for payment, scheduling travel, etc. It will also coordinate the biannual visits/meetings of the External Advisory Committee and communicate minutes of these meetings to NCRR staff. The core will handle the logistics and record minutes of the monthly meetings of COBRE personnel. In addition, we propose to establish a seminar series in Tumor Cell Biology, featuring nationally prominent oncology researchers. This program will be coordinated by Dr. Gary Rankin, one of the mentors, who also oversees the Visiting Scholars Seminar Program in the School of Medicine. Lastly, we propose to establish a pilot grant program in order to encourage other non- COBRE faculty members to initiate research in cancer biology that fits into the scientific theme of this COBRE. This mechanism should increase the critical mass of investigators involved in cancer research and ensure continued success of the COBRE center once NCRR funding has ended.e=n¿?
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。根据COBRE指导方针的要求,将建立一个行政核心,并由PI Niles博士指导。该核心将负责COBRE的所有财务方面。这将包括跟踪单个项目/核心预算,下订单,批准付款发票,安排旅行等。它还将协调外部咨询委员会一年两次的访问/会议,并将这些会议的纪要送交国家人权中心的工作人员。核心将处理COBRE人员每月会议的后勤和记录记录。此外,我们建议建立肿瘤细胞生物学系列研讨会,邀请全国知名肿瘤研究人员参加。该项目将由导师之一Gary Rankin博士协调,他也负责监督医学院的访问学者研讨会项目。最后,我们建议建立一个试点资助计划,以鼓励其他非COBRE教师发起符合本COBRE科学主题的癌症生物学研究。这一机制将增加参与癌症研究的研究人员的临界质量,并确保在NCRR资金结束后COBRE中心继续取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard M. Niles其他文献
Expression of TGF-β during in vitro differentiation of hamster tracheal epithelial cells
- DOI:
10.1007/bf02632048 - 发表时间:
1994-04-01 - 期刊:
- 影响因子:1.700
- 作者:
Richard M. Niles;Nancy L. Thompson;Faustina Fenton - 通讯作者:
Faustina Fenton
Adenylate cyclase activity in cultured epithelial cells
- DOI:
10.1007/bf02615137 - 发表时间:
1977-08-01 - 期刊:
- 影响因子:1.900
- 作者:
Richard M. Niles;Joseph S. Makarski;Nicholas Ballinger;Hwakyu Kim;Alexander M. Rutenburg - 通讯作者:
Alexander M. Rutenburg
High extracellular fibrinolytic activity of tumors and control normal tissues
- DOI:
10.1016/s0006-291x(75)80216-6 - 发表时间:
1975-07-22 - 期刊:
- 影响因子:
- 作者:
Bakshy A. Chibber;Richard M. Niles;Liisa Prehn;Sam Sorof - 通讯作者:
Sam Sorof
Retinoic acid-induced arrest of mouse melanoma cells in G1 without inhibition of protein synthesis
- DOI:
10.1007/bf02620957 - 发表时间:
1987-12-01 - 期刊:
- 影响因子:1.900
- 作者:
Richard M. Niles - 通讯作者:
Richard M. Niles
Richard M. Niles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard M. Niles', 18)}}的其他基金
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers
对非致病性细菌进行生物工程以生产医学相关的生物聚合物
- 批准号:
8977656 - 财政年份:2015
- 资助金额:
$ 44.14万 - 项目类别:
Bioengineering a non-pathogenic bacteria to produce medically-relevant biopolymers
对非致病性细菌进行生物工程以生产医学相关的生物聚合物
- 批准号:
9345681 - 财政年份:2015
- 资助金额:
$ 44.14万 - 项目类别:
RARbeta in Melanoma: Epigenetic Regulation by Nutrients
黑色素瘤中的 RARbeta:营养素的表观遗传调控
- 批准号:
7291022 - 财政年份:2006
- 资助金额:
$ 44.14万 - 项目类别:
RARbeta in Melanoma: Epigenetic Regulation by Nutrients
黑色素瘤中的 RARbeta:营养素的表观遗传调控
- 批准号:
7179001 - 财政年份:2006
- 资助金额:
$ 44.14万 - 项目类别:
相似海外基金
Administrative Core COBRE Phase III Stem Cells and Aging
行政核心 COBRE III 期干细胞和衰老
- 批准号:
10630388 - 财政年份:2023
- 资助金额:
$ 44.14万 - 项目类别:
Administrative Supplement to Hepatobiology and Toxicology COBRE
肝生物学和毒理学 COBRE 行政增刊
- 批准号:
10399887 - 财政年份:2021
- 资助金额:
$ 44.14万 - 项目类别:
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10399734 - 财政年份:2021
- 资助金额:
$ 44.14万 - 项目类别:
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10582060 - 财政年份:2020
- 资助金额:
$ 44.14万 - 项目类别:
Administrative Supplement: COBRE in Pharmaceutical Research and Innovation
行政补充:COBRE 药物研究与创新
- 批准号:
10794454 - 财政年份:2020
- 资助金额:
$ 44.14万 - 项目类别:
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
COBRE 抗菌素耐药性和治疗发现中心 - 行政核心
- 批准号:
10224225 - 财政年份:2018
- 资助金额:
$ 44.14万 - 项目类别:
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
COBRE 抗菌素耐药性和治疗发现中心 - 行政核心
- 批准号:
10488622 - 财政年份:2018
- 资助金额:
$ 44.14万 - 项目类别:














{{item.name}}会员




